Trexquant Investment LP Stoke Therapeutics, Inc. Transaction History

Trexquant Investment LP

$8.06 Billion
Q4 2024

A detailed history of Trexquant Investment LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 103,031 shares of STOK stock, worth $742,853. This represents 0.01% of its overall portfolio holdings.

Number of Shares

103,031

Previous 161,749 36.3%

Holding current value

$742,853

Previous $1.99 Million 42.83%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$10.8 - $13.92 $634,154 - $817,354	-58,718 Reduced 36.3%	103,031 $1.14 Million
Q3 2024 Nov 12, 2024	SELL	$12.24 - $15.92 $218,655 - $284,394	-17,864 Reduced 9.95%	161,749 $1.99 Million
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $1.64 Million - $2.6 Million	148,637 Added 479.85%	179,613 $2.43 Million
Q1 2024 May 14, 2024	SELL	$4.12 - $14.17 $36,354 - $125,036	-8,824 Reduced 22.17%	30,976 $418,000
Q4 2023 Feb 09, 2024	SELL	$3.37 - $5.4 $295,821 - $474,017	-87,781 Reduced 68.8%	39,800 $209,000
Q3 2023 Nov 13, 2023	BUY	$3.78 - $11.99 $301,587 - $956,622	79,785 Added 166.93%	127,581 $502,000
Q2 2023 Aug 11, 2023	SELL	$7.93 - $13.82 $617,183 - $1.08 Million	-77,829 Reduced 61.95%	47,796 $508,000
Q1 2023 May 15, 2023	BUY	$7.65 - $10.38 $291,434 - $395,436	38,096 Added 43.52%	125,625 $1.05 Million
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $266,348 - $591,089	37,673 Added 75.56%	87,529 $807,000
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $424,540 - $761,536	-33,801 Reduced 40.4%	49,856 $640,000
Q2 2022 Aug 11, 2022	BUY	$10.36 - $23.93 $699,413 - $1.62 Million	67,511 Added 418.13%	83,657 $1.11 Million
Q1 2022 May 13, 2022	SELL	$17.19 - $26.1 $176,249 - $267,603	-10,253 Reduced 38.84%	16,146 $340,000
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $478,085 - $810,977	26,399 New	26,399 $633,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $211,643 - $308,203	-8,949 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$30.53 - $41.09 $32,148 - $43,267	1,053 Added 13.34%	8,949 $301,000
Q1 2021 May 13, 2021	BUY	$36.08 - $69.81 $284,887 - $551,219	7,896 New	7,896 $307,000

Others Institutions Holding STOK

# of Institutions

135

Shares Held

57.2M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $284M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Stoke Therapeutics, Inc. Transaction History